Clinical Trial Update: Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial comparing delayed-release versus immediate-release risedronate in postmenopausal osteoporosis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Warner Chilcott | Conditions: Postmenopausal Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2011-03-24